Published on 15 Nov 2022 on Zacks via Yahoo Finance
Nemaura Medical, Inc. (NMRD) Reports Q2 Loss, Misses Revenue Estimates
Nemaura Medical, Inc. (NMRD) came out with a quarterly loss of $0.17 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago. These figures are adjusted for non-recurring items.
A quarter ago, it was expected that this company would post a loss of $0.16 per share when it actually produced a loss of $0.17, delivering a surprise of -6.25%.
Over the last four quarters, the company has not been able to surpass consensus EPS estimates.